737 related articles for article (PubMed ID: 19889791)
1. Imipramine, in part through tumor necrosis factor alpha inhibition, prevents cognitive decline and beta-amyloid accumulation in a mouse model of Alzheimer's disease.
Chavant F; Deguil J; Pain S; Ingrand I; Milin S; Fauconneau B; Pérault-Pochat MC; Lafay-Chebassier C
J Pharmacol Exp Ther; 2010 Feb; 332(2):505-14. PubMed ID: 19889791
[TBL] [Abstract][Full Text] [Related]
2. Restraining tumor necrosis factor-alpha by thalidomide prevents the amyloid beta-induced impairment of recognition memory in mice.
Alkam T; Nitta A; Mizoguchi H; Saito K; Seshima M; Itoh A; Yamada K; Nabeshima T
Behav Brain Res; 2008 May; 189(1):100-6. PubMed ID: 18325608
[TBL] [Abstract][Full Text] [Related]
3. Silibinin attenuates amyloid beta(25-35) peptide-induced memory impairments: implication of inducible nitric-oxide synthase and tumor necrosis factor-alpha in mice.
Lu P; Mamiya T; Lu LL; Mouri A; Niwa M; Hiramatsu M; Zou LB; Nagai T; Ikejima T; Nabeshima T
J Pharmacol Exp Ther; 2009 Oct; 331(1):319-26. PubMed ID: 19638571
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of Z-ligustilide against amyloid beta-induced neurotoxicity is associated with decreased pro-inflammatory markers in rat brains.
Kuang X; Du JR; Chen YS; Wang J; Wang YN
Pharmacol Biochem Behav; 2009 Jun; 92(4):635-41. PubMed ID: 19324070
[TBL] [Abstract][Full Text] [Related]
5. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease.
Olcese JM; Cao C; Mori T; Mamcarz MB; Maxwell A; Runfeldt MJ; Wang L; Zhang C; Lin X; Zhang G; Arendash GW
J Pineal Res; 2009 Aug; 47(1):82-96. PubMed ID: 19538338
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen-rich saline improves memory function in a rat model of amyloid-beta-induced Alzheimer's disease by reduction of oxidative stress.
Li J; Wang C; Zhang JH; Cai JM; Cao YP; Sun XJ
Brain Res; 2010 Apr; 1328():152-61. PubMed ID: 20171955
[TBL] [Abstract][Full Text] [Related]
7. The role of TNF-alpha signaling pathway on COX-2 upregulation and cognitive decline induced by beta-amyloid peptide.
Medeiros R; Figueiredo CP; Pandolfo P; Duarte FS; Prediger RD; Passos GF; Calixto JB
Behav Brain Res; 2010 May; 209(1):165-73. PubMed ID: 20122965
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy against APP beta-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain abeta levels.
Rakover I; Arbel M; Solomon B
Neurodegener Dis; 2007; 4(5):392-402. PubMed ID: 17536186
[TBL] [Abstract][Full Text] [Related]
9. Orally available compound prevents deficits in memory caused by the Alzheimer amyloid-beta oligomers.
Townsend M; Cleary JP; Mehta T; Hofmeister J; Lesne S; O'Hare E; Walsh DM; Selkoe DJ
Ann Neurol; 2006 Dec; 60(6):668-76. PubMed ID: 17192927
[TBL] [Abstract][Full Text] [Related]
10. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
Arendash GW; Schleif W; Rezai-Zadeh K; Jackson EK; Zacharia LC; Cracchiolo JR; Shippy D; Tan J
Neuroscience; 2006 Nov; 142(4):941-52. PubMed ID: 16938404
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effects of Eucommia ulmoides Oliv. Bark on amyloid beta(25-35)-induced learning and memory impairments in mice.
Kwon SH; Lee HK; Kim JA; Hong SI; Kim SY; Jo TH; Park YI; Lee CK; Kim YB; Lee SY; Jang CG
Neurosci Lett; 2011 Jan; 487(1):123-7. PubMed ID: 20974223
[TBL] [Abstract][Full Text] [Related]
12. Differential susceptibility following beta-amyloid peptide-(1-40) administration in C57BL/6 and Swiss albino mice: Evidence for a dissociation between cognitive deficits and the glutathione system response.
Prediger RD; Franco JL; Pandolfo P; Medeiros R; Duarte FS; Di Giunta G; Figueiredo CP; Farina M; Calixto JB; Takahashi RN; Dafre AL
Behav Brain Res; 2007 Feb; 177(2):205-13. PubMed ID: 17194489
[TBL] [Abstract][Full Text] [Related]
13. Genetic deletion or antagonism of kinin B(1) and B(2) receptors improves cognitive deficits in a mouse model of Alzheimer's disease.
Prediger RD; Medeiros R; Pandolfo P; Duarte FS; Passos GF; Pesquero JB; Campos MM; Calixto JB; Takahashi RN
Neuroscience; 2008 Feb; 151(3):631-43. PubMed ID: 18191900
[TBL] [Abstract][Full Text] [Related]
14. Beta-amyloid (1-42)-induced learning and memory deficits in mice: involvement of oxidative burdens in the hippocampus and cerebral cortex.
Jhoo JH; Kim HC; Nabeshima T; Yamada K; Shin EJ; Jhoo WK; Kim W; Kang KS; Jo SA; Woo JI
Behav Brain Res; 2004 Dec; 155(2):185-96. PubMed ID: 15364477
[TBL] [Abstract][Full Text] [Related]
15. Chronic nicotine restores normal Aβ levels and prevents short-term memory and E-LTP impairment in Aβ rat model of Alzheimer's disease.
Srivareerat M; Tran TT; Salim S; Aleisa AM; Alkadhi KA
Neurobiol Aging; 2011 May; 32(5):834-44. PubMed ID: 19464074
[TBL] [Abstract][Full Text] [Related]
16. Melatonin alleviates behavioral deficits associated with apoptosis and cholinergic system dysfunction in the APP 695 transgenic mouse model of Alzheimer's disease.
Feng Z; Chang Y; Cheng Y; Zhang BL; Qu ZW; Qin C; Zhang JT
J Pineal Res; 2004 Sep; 37(2):129-36. PubMed ID: 15298672
[TBL] [Abstract][Full Text] [Related]
17. Arginine vasopressin prevents amyloid beta protein-induced impairment of long-term potentiation in rat hippocampus in vivo.
Jing W; Guo F; Cheng L; Zhang JF; Qi JS
Neurosci Lett; 2009 Feb; 450(3):306-10. PubMed ID: 19059464
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease.
He J; Luo H; Yan B; Yu Y; Wang H; Wei Z; Zhang Y; Xu H; Tempier A; Li X; Li XM
Neurobiol Aging; 2009 Aug; 30(8):1205-16. PubMed ID: 18079026
[TBL] [Abstract][Full Text] [Related]
19. Cognitive dysfunction induced by sequential injection of amyloid-beta and ibotenate into the bilateral hippocampus; protection by memantine and MK-801.
Nakamura S; Murayama N; Noshita T; Katsuragi R; Ohno T
Eur J Pharmacol; 2006 Oct; 548(1-3):115-22. PubMed ID: 16952349
[TBL] [Abstract][Full Text] [Related]
20. The nootropic and neuroprotective proline-containing dipeptide noopept restores spatial memory and increases immunoreactivity to amyloid in an Alzheimer's disease model.
Ostrovskaya RU; Gruden MA; Bobkova NA; Sewell RD; Gudasheva TA; Samokhin AN; Seredinin SB; Noppe W; Sherstnev VV; Morozova-Roche LA
J Psychopharmacol; 2007 Aug; 21(6):611-9. PubMed ID: 17092975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
